De novo combination therapy in retroviral infection

5Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Many plant-based medicines being used in treatment of HIV infections, but no scientific evidence are available to support their use. A number of synthetic, semi synthetic as well as drug of natural origin are reported to be active against HIV. In the present study, various drugs of plants and synthetic drugs have been discussed for some future beneficial combinations for formulations against viral infections. The combination therapy of the mentioned herbal agents with synthetic drugs might be beneficial for the treatment of retroviral infections in future due to better compatibility, potency and synergistic activities. New era of therapy can be developed by combination of synthetic, semi synthetic and natural drugs in pharmaceutical formulations. © 2010 Academic Journals Inc.

Cite

CITATION STYLE

APA

Kadam, N. M., Chaudhari, H. S., Parikh, J. K., Modi, V. S., Kokil, S. U., & Balaramnavar, V. M. (2010). De novo combination therapy in retroviral infection. International Journal of Virology, 6(4), 219–223. https://doi.org/10.3923/ijv.2010.219.223

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free